← Back to Search

Video Capsule Endoscopy

Video Capsule Endoscopy for Vomiting Blood

N/A
Waitlist Available
Led By David R Cave, MD, PhD
Research Sponsored by Christopher Marshall
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment to one year
Awards & highlights

Study Summary

This trial will compare the use of a video capsule endoscopy to the standard of care workup for patients with symptoms of gastrointestinal bleeding.

Eligible Conditions
  • Gastrointestinal Bleeding
  • Vomiting Blood
  • Black Stool

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment to one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment to one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Detection of Bleeding
Time to Detection of Bleeding
Secondary outcome measures
Admission Rate
Endoscopic Procedures
Hospital Length of Stay
+2 more
Other outcome measures
Blood Product Transfusions
Complication Rates

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Early Capsule GroupExperimental Treatment1 Intervention
The intervention for subjects in this arm will be to have a video capsule deployed as soon as possible after presentation to the clinical decision unit. Information from the video capsule will be obtained and reviewed to determine location of bleeding. Once that information has been obtained a decision will be made on which endoscopic test is most pertinent in finding and treating the source of bleeding.
Group II: Standard of Care Work-upActive Control1 Intervention
In this arm, patients will receive "standard of care workup" for non-hematemesis gastrointestinal bleeding. This could include upper endoscopy, colonoscopy, and additional capsule or small bowel enteroscopy depending on the subject's presentation and the results of the workup performed by the gastroenterology team. For patients requiring a video capsule endoscopy as part of "standard of care workup" the patients will be given the same Olympus video capsule that is used in the "Early Capsule" group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Video Capsule Endoscopy
2020
N/A
~40

Find a Location

Who is running the clinical trial?

Olympus Corporation of the AmericasIndustry Sponsor
20 Previous Clinical Trials
2,180 Total Patients Enrolled
Christopher MarshallLead Sponsor
David CaveLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the essential purpose of this trial?

"The primary aim of this study, which lasts for a maximum duration of 720 hours or the time taken to detect bleeding (whichever is sooner), is to measure the rate of detection of bleeding. Secondary objectives include evaluating the number of invasive procedures, re-admission rates and therapeutic procedures administered throughout the trial period."

Answered by AI

To what extent is this research endeavor being utilized by the general public?

"Affirmative, clinicaltrials.gov data indicates that recruitment for this research project is still open and actively being pursued. Initially posted on February 4th 2020 and last edited March 12th 2022, 160 patients are needed from a single site."

Answered by AI

Has recruitment for this experiment been closed or is it ongoing?

"As indicated on clinicaltrials.gov, this research is currently recruiting participants; the trial was initially advertised on February 4th 2020 and recently updated on March 12th 2022."

Answered by AI
~7 spots leftby Apr 2025